Subscribe to our Newsletters !!

    Kumar Jeetendra

    Mylab gets ICMR gesture for its antigen testing unit for COVID-19

    Pune-based Mylab Discovery Solutions on Wednesday said it has received commercial approval from the Indian Council for Medical Research (ICMR) for its antigen testing kit for COVID-19. The product called,’Pathocatch COVID-19 Antigen Quick testing kit’, is developed and manufactured in India, Mylab said in a statement. The kit will be available for orders immediately and

    Lab-made infection mirrors COVID-19 infection: Research

    Airborne and potentially deadly, the virus which causes COVID-19 can only be studied safely under high level biosafety conditions. Scientists handling the virus that is infectious must wear full-body biohazard matches with pressurized respirators, and operate inside labs with multiple containment degrees and technical ventilation systems. While necessary to protect laboratory employees, these security precautions

    WHO chief researcher sees no group invulnerability yet

    The chief scientist at the World Health Organization estimates that approximately 50 percent to 60% of the population will have to be resistant to the coronavirus for there to be some protective”herd immunity” effect. Herd immunity is normally achieved through vaccination and occurs when most of a population is immune to a disease, obstructing its

    Chinese COVID-19 antibody up-and-comer shows guarantee in animal tests

    Animal tests of an expected COVID-19 vaccine being developed by Chinese researchers demonstrate it triggers an immune reaction against the novel coronavirus, offering some promise since it goes into early-stage human trials, according to a peer-reviewed study. ARCoV is a messenger RNA vaccine which uses technology like applicants being manufactured by Moderna and BioNtech and

    Test mRNA-based COVID-19 immunization evokes defensive safe reactions in animals

    Two injections of this vaccine were enough to induce robust immunity, completely preventing SARS-CoV-2 infection in mice. MRNA-based vaccines are all attractive options for protecting against SARS-CoV-2 because they may be quickly designed and manufactured at a huge scale within weeks. Moreover, preclinical studies have shown that mRNA-based vaccines cause potent and broadly protective immune

    Sent Colorectal Cancer Kits May Increase Screening Rates

    Mailing colorectal cancer screening kits to Medicaid enrollees is a more cost-effective way to boost screening rates, according to new research from the University of North Carolina. Colorectal cancer is one of the most frequently diagnosed cancers, but routine screening (such as colonoscopies and at-home feces screening ) can identify cases early, when treatment is

    AdvaMed Unveils National Covid-19 Testing Registry

    The Advanced Medical Technology Association (AdvaMed) has made a detailed, nationwide covid-19 diagnostic supply registry to assist state and federal governments in their own wing responses. The national registry has been launched in partnership with 13 commercial diagnostics makers: Abbott, BD, bioMérieux, Bio-Rad, Beckman Coulter, Cepheid, Hologic, Ortho Clinical Diagnostics, Qiagen, Roche Diagnostics, Sekisui Diagnostics,